Clinical
New clinical trial registered for TB-500
Related compound: TB-500View source →
TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD (NCT07487363) registered on ClinicalTrials.gov. Phase: phase 2. Status: recruiting.